JUNSHI BIO (01877) announced that the company will strictly control risks in accordance with relevant regulations and intends to invest temporarily idle raised funds in safe, highly liquid principal-guaranteed investment products (including but not limited to call deposits, time deposits, agreement deposits, composite deposits, certificates of deposit, and structured deposits). These products will not be used for pledging or securities investment purposes.

The company plans to allocate up to RMB 2.4 billion (inclusive) of temporarily idle raised funds for cash management. Based on the utilization of raised funds and the company's operational needs, the idle funds will be invested in the aforementioned products in tranches with varying terms, not exceeding 12 months. Within the specified quota and period, the funds can be rolled over for repeated use.